John Bencich Insider Trading $ACHV ACHIEVE LIFE SCIENCES, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for John Bencich.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of John Bencich. John Bencich is CEO in ACHIEVE LIFE SCIENCES, INC. ($ACHV) and CFO in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and CFO & COO in ACHIEVE LIFE SCIENCES, INC. ($OGXI) and V.P. and CFO in Trubion Pharmaceuticals, Inc ($TRBN).

John Bencich in ACHIEVE LIFE SCIENCES, INC.

Trading Symbol: ACHV
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of John Bencich: CEO, CFO & COO, CFO
Holdings: 174 shares
Current Value: $104
Latest Transaction: Jan 28 2021
$ACHV Market Capitalization: $18.31M
$ACHV Previous Close: $0.60

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of John Bencich in ACHIEVE LIFE SCIENCES, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACHV, TRBN

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 28 2021ACHVACHIEVE LIFE SCIEN ...Bencich JohnCEOOption ExerciseA13.0960,000785,40060,000
Jan 28 2021ACHVACHIEVE LIFE SCIEN ...Bencich JohnCEOOption ExerciseA0.0015,000015,000
Aug 19 2020ACHVACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOOption ExerciseM0.0069068
Aug 19 2020ACHVACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOPayment of ExerciseF8.9533295141174 to 141 (-18.97 %)
Aug 19 2020ACHVACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOBuyM0.00690174105 to 174 (+65.71 %)
Jan 30 2020ACHVACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOOption ExerciseA0.56200,000112,000200,000
Aug 15 2019ACHVACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOOption ExerciseM0.001,37002,740
Aug 15 2019ACHVACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOPayment of ExerciseF1.884087672,1012.5 K to 2.1 K (-16.26 %)
Aug 15 2019ACHVACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOBuyM0.001,37002,5091.1 K to 2.5 K (+120.28 %)
Jan 31 2019OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOOption ExerciseA1.4210,00014,20010,000
Jan 31 2019OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOOption ExerciseA1.4230,00042,60030,000
Jan 17 2019OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOOption ExerciseM0.002800
Jan 17 2019OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOPayment of ExerciseF1.169101,1391.1 K to 1.1 K (-0.78 %)
Jan 17 2019OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOBuyM0.002801,1481.1 K to 1.1 K (+2.50 %)
Sep 21 2018OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOOption ExerciseA2.5650,000128,00050,000
Aug 15 2018OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOOption ExerciseM0.0028028
Aug 15 2018OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOOption ExerciseM0.004500
Aug 15 2018OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOOption ExerciseM0.001,37004,110
Aug 15 2018OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOPayment of ExerciseF2.784581,2731,1201.6 K to 1.1 K (-29.02 %)
Aug 15 2018OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOBuyM0.001,44301,578135 to 1.6 K (+1,068.89 %)
Jul 30 2018OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOOption ExerciseA3.3725,00084,25025,000
Jul 30 2018OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFO & COOOption ExerciseA3.3725,00084,25025,000
Sep 12 2017OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFOOption ExerciseM0.004540455
Sep 12 2017OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFOPayment of ExerciseF3.091494601,3581.5 K to 1.4 K (-9.89 %)
Sep 12 2017OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFOBuyM0.0045401,5071.1 K to 1.5 K (+43.11 %)
Aug 03 2017OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFOOption ExerciseA4.57274,0001,252,180274,000
Aug 03 2017OGXIACHIEVE LIFE SCIEN ...Bencich JohnCFOOption ExerciseA0.0054,800054,800
Jan 12 2017OGXIONCOGENEX PHARMACE ...Bencich JohnCFOOption ExerciseM0.003,12506,250
Jan 12 2017OGXIONCOGENEX PHARMACE ...Bencich JohnCFOPayment of ExerciseF0.631,02164311,58812.6 K to 11.6 K (-8.10 %)
Jan 12 2017OGXIONCOGENEX PHARMACE ...Bencich JohnCFOBuyM0.003,125012,6099.5 K to 12.6 K (+32.95 %)
Aug 23 2016OGXIONCOGENEX PHARMACE ...Bencich JohnCFOOption ExerciseM0.005,000010,000
Aug 23 2016OGXIONCOGENEX PHARMACE ...Bencich JohnCFOSellS0.571,3807879,48410.9 K to 9.5 K (-12.70 %)
Aug 23 2016OGXIONCOGENEX PHARMACE ...Bencich JohnCFOBuyM0.005,00005,0000 to 5 K
Mar 16 2016OGXIONCOGENEX PHARMACE ...Bencich JohnCFOOption ExerciseA0.85112,50095,625112,500
Mar 16 2016OGXIONCOGENEX PHARMACE ...Bencich JohnCFOOption ExerciseM0.003,12509,375
Mar 16 2016OGXIONCOGENEX PHARMACE ...Bencich JohnCFOSellS0.838346925,8646.7 K to 5.9 K (-12.45 %)
Mar 16 2016OGXIONCOGENEX PHARMACE ...Bencich JohnCFOBuyM0.003,12506,6983.6 K to 6.7 K (+87.46 %)
Aug 20 2015OGXIONCOGENEX PHARMACE ...Bencich JohnCFOOption ExerciseM0.005,000015,000
Aug 20 2015OGXIONCOGENEX PHARMACE ...Bencich JohnCFOSellS2.761,4273,9393,5735 K to 3.6 K (-28.54 %)
Aug 20 2015OGXIONCOGENEX PHARMACE ...Bencich JohnCFOBuyM0.005,00005,0000 to 5 K
May 21 2015OGXIONCOGENEX PHARMACE ...Bencich JohnCFOOption ExerciseA1.8625,00046,50025,000
May 21 2015OGXIONCOGENEX PHARMACE ...Bencich JohnCFOOption ExerciseA0.0012,500012,500

Page:   1